Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
British Journal of Clinical Pharmacology|September 2, 2022
Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept studyRené J Boosman, Nikki de Rouw, Alwin D R Huitema, et al.Drug Safety|November 6, 2021
Mechanisms, Management and Prevention of Pemetrexed-Related ToxicityNikki de Rouw, Berber Piet, Hieronymus J Derijks, et al.Biomedical Chromatography : BMC|November 6, 2021
Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studiesEleonora W J van Ewijk-Beneken Kolmer, Marga J A Teulen, Rene J Boosman, et al.Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.Hemodialysis International. International Symposium on Home Hemodialysis|November 14, 2023
Effect of conventional hemodialysis on the apixaban plasma concentrationTim Poel, Nikki de Rouw, Nathalie C V Péquériaux, et al.Journal of Biomolecular Screening|August 30, 2011
Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput wayJoost C M Uitdehaag, Cecile M Sünnen, Antoon M van Doornmalen, et al.Cancer Chemotherapy and Pharmacology|December 20, 2019
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functionsNikki de Rouw, Sabine Visser, Stijn L W Koolen, et al.Clinical Pharmacology and Therapeutics|January 20, 2022
The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung CancerNikki de Rouw, Merel de Boer, René J Boosman, et al.Clinical Pharmacokinetics|January 9, 2021
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic AnalysisNikki de Rouw, Rene J Boosman, Alwin D R Huitema, et al.BMJ Open|April 25, 2025
Omission of dexamethasone in paclitaxel premedication regimens: protocol of the multicentre, randomised, non-inferiority DEXASTOP trialMichiel Zietse, Luuk C Aalders, Leontine E A M M Spierings, et al.Pageof 2